Precision Biosciences Inc
DTIL
Revenue
49.90M
▲32.31M▲183.77%
3 Months ChangeAssets
165.80M
▼-18.94M▼-10.25%
3 Months ChangeLiabilities
91.09M
▼-56.45M▼-38.26%
3 Months ChangeFree Cash Flow
-19.07M
▲12.92M▲40.39%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-24
Form 8-K
ID: 0000950170-24-116864
2024-09-12
Form 8-K
ID: 0000950170-24-105706
2024-09-03
Form 8-K
ID: 0000950170-24-102561
2024-08-01
Form 10-Q
ID: 0000950170-24-088951
2024-08-01
Form 8-K
ID: 0000950170-24-088950
2024-06-10
Form 8-K
ID: 0000950170-24-071082
2024-05-13
Form 10-Q
ID: 0000950170-24-058192
2024-05-13
Form 8-K
ID: 0000950170-24-058191
2024-05-08
Form 8-K
ID: 0000950170-24-055089
2024-04-16
Form 8-K
ID: 0000950170-24-044831